Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Saudi Arabia · Delayed Price · Currency is SAR

29.20

-0.44 (-1.48%)

At close: Feb 11, 2026

TADAWUL:2070 Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	128.73	24.54	-50.73	-165.14	26.45	124.79
Depreciation & Amortization	95.49	78.84	76.19	84.93	83.66	82.33
Other Amortization	5.86	5.86	5.82	3.89	4.44	5.09
Loss (Gain) From Sale of Assets	-47.46	-18.94	-6.38	-0.14	0.45	-
Asset Writedown & Restructuring Costs	18.09	17.37	0.05	-	-	2.39
Loss (Gain) From Sale of Investments	11.68	37.06	42.05	-3.63	-7.81	-3.52
Loss (Gain) on Equity Investments	-28.74	-22.73	-20	-20.44	-11.41	-38.21
Stock-Based Compensation	5.15	1.18	-	-	-	-
Provision & Write-off of Bad Debts	-	-	-	10.05	-13.86	1.48
Other Operating Activities	-13.32	-73.93	160.41	11.05	-6.84	22.48
Change in Accounts Receivable	16.67	-341.48	-190.08	172.69	18.02	-51.67
Change in Inventory	-48.28	-49.6	-143.03	-76.56	13.02	-44.35
Change in Accounts Payable	74.98	116.37	128.35	-57.96	-14.27	-105.85
Change in Other Net Operating Assets	-45.39	-105.5	8.22	-44.37	-3	18.38
Operating Cash Flow	180.66	-330.96	10.87	-99.3	86.71	9.74
Operating Cash Flow Growth	-	-	-	-	790.67%	-97.24%
Capital Expenditures	-61.61	-71.27	-106.79	-78.21	-76.24	-164.75
Sale of Property, Plant & Equipment	70.04	35.55	7.53	0.65	1.02	2.03
Sale (Purchase) of Intangibles	-29.9	-31.01	-5.94	-	-1	-10.4
Investment in Securities	-68.15	-39.5	-70.5	525.89	193.74	-5.85
Other Investing Activities	13.19	13.19	8.75	36.3	23.97	32.38
Investing Cash Flow	-76.43	-93.05	-166.94	484.63	141.48	-146.59
Long-Term Debt Issued	-	1,290	1,497	-	14.47	139.55
Long-Term Debt Repaid	-	-894.41	-1,462	-220.55	-81.35	-4.4
Net Debt Issued (Repaid)	-157.34	395.82	34.61	-220.55	-66.87	135.15
Repurchase of Common Stock	-	-11.94	-8	-	-	-
Common Dividends Paid	-1.93	-2.78	-0.46	-70.74	-118.11	-58.98
Other Financing Activities	-	-	-26.19	-49.86	-55.97	2.68
Financing Cash Flow	-159.27	381.11	-0.04	-341.15	-240.95	78.85
Foreign Exchange Rate Adjustments	-1.43	1.95	-16.15	-38.5	8.35	13.1
Net Cash Flow	-56.47	-40.95	-172.26	5.69	-4.42	-44.89
Free Cash Flow	119.05	-402.23	-95.92	-177.51	10.47	-155.02
Free Cash Flow Margin	7.06%	-23.91%	-5.79%	-12.48%	0.72%	-9.97%
Free Cash Flow Per Share	1.00	-3.37	-0.80	-1.48	0.09	-1.29
Cash Interest Paid	102.52	108.15	69.82	33.41	20.26	26.73
Cash Income Tax Paid	-	-	-	-	0.54	3.97
Levered Free Cash Flow	106.63	-354.87	41.76	-121.09	-56.73	-182.43
Unlevered Free Cash Flow	167.85	-300.64	81.45	-99.63	-37.11	-161.43
Change in Working Capital	5.18	-380.21	-196.54	-6.2	13.78	-183.49

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.